WORK to Save Lives Act
Sponsored By: Representative Rep. Watson Coleman, Bonnie [D-NJ-12]
Introduced
Summary
Expand workplace access to opioid overdose reversal medication and training. This bill would require federal agencies to acquire and maintain opioid overdose reversal medication and offer voluntary annual training to employees, and it would direct the Secretary of Labor, through OSHA, to publish nonmandatory guidance for most employers within 270 days.
Show full summary
- Federal agencies: Would be required to acquire and maintain opioid overdose reversal medication and offer voluntary annual employee training. The Veterans Health Administration is explicitly included.
- Private employers: OSHA would issue nonbinding guidance on acquiring and maintaining the medication and on offering annual voluntary training. The United States Postal Service is excluded from the employer definition for that guidance.
- Workers and workplaces: Employees would be offered voluntary annual training on using overdose reversal medication and workplaces would be encouraged to keep kits on site.
Your PRIA Score
Personalized for You
How does this bill affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this bill and every other piece of legislation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Bill Overview
Analyzed Economic Effects
2 provisions identified: 2 benefits, 0 costs, 0 mixed.
Required naloxone and training in Federal workplaces
This bill would require the Secretary of Labor, through OSHA, to issue regulations within 270 days. The regulations would require each Federal agency to acquire and maintain opioid overdose reversal medication (naloxone) and to offer voluntary annual training to employees on how to use it. The bill would define 'Federal agency' to include any agency or instrumentality of the Federal Government, explicitly including the Veterans Health Administration. These requirements would be binding on federal agencies.
Voluntary naloxone guidance for employers
This bill would require the Secretary of Labor, through OSHA, to publish nonmandatory guidance for employers within 270 days. The guidance would cover how to acquire and maintain opioid overdose reversal medication (naloxone) and how to offer voluntary annual employee training on its use. For this guidance, 'employer' would mean the OSHA definition in the Occupational Safety and Health Act, except the United States Postal Service would be excluded. The guidance would be voluntary and would not create a legal requirement for private employers.
Free Policy Watch
You just read the policy. Now see what it costs you.
Pick a topic. PRIA runs your household against live legislation and sends you a free personalized readout.
Pick a topic to get started
Sponsors & CoSponsors
Sponsor
Rep. Watson Coleman, Bonnie [D-NJ-12]
NJ • D
Cosponsors
Rutherford
FL • R
Sponsored 2/10/2026
Rep. Tlaib, Rashida [D-MI-12]
MI • D
Sponsored 2/10/2026
Rep. McIver, LaMonica [D-NJ-10]
NJ • D
Sponsored 2/10/2026
Craig
MN • D
Sponsored 2/10/2026
Rep. Budzinski, Nikki [D-IL-13]
IL • D
Sponsored 2/10/2026
Rep. Amo, Gabe [D-RI-1]
RI • D
Sponsored 2/10/2026
Rep. Davis, Danny K. [D-IL-7]
IL • D
Sponsored 2/10/2026
Rep. Thanedar, Shri [D-MI-13]
MI • D
Sponsored 2/10/2026
Rep. Goldman, Daniel S. [D-NY-10]
NY • D
Sponsored 2/10/2026
McClain Delaney
MD • D
Sponsored 2/10/2026
Rep. Carson, Andre [D-IN-7]
IN • D
Sponsored 2/10/2026
Del. Norton, Eleanor Holmes [D-DC-At Large]
DC • D
Sponsored 2/10/2026
Grijalva
AZ • D
Sponsored 2/10/2026
Rep. Jackson, Jonathan L. [D-IL-1]
IL • D
Sponsored 3/9/2026
Roll Call Votes
No roll call votes available for this bill.
View on Congress.govTake It Personal
Get Your Personalized Policy View
Take the PRIA Score to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in